Level C· Early human research exploring benefitsProspective StudyPubMed

[Effectiveness of autologous cells of stromal-vascular fraction of adipose tissue depending on transplantation method for skin grafting in patients with extensive deep burns].

Alekseev AA., Filimonov KA., Astrelina TA., Kobzeva IV., Bobrovnikov AE., Khromina SS.

Prospective Study with a reported sample of 43 on Burns, published in Khirurgiia (Mosk) (2026) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Prospective Study
Journal
Khirurgiia (Mosk) (2026)
Country
Russia (Federation)
Reported sample size
43
Source database
PubMed
PMID
41717747
DOI
10.17116/hirurgia202602163

Abstract (original English)

To analyze different methods for autologous transplantation of stromal-vascular fraction of adipose tissue combined with skin grafting with split-thickness skin graft 1:6 in patients with extensive deep burns. Open comparative controlled prospective study was devoted to results of autologous skin grafting with split-thickness skin graft 1:6 and autologous cells of stromal-vascular fraction of adipose tissue. Patients were divided into 4 groups depending on transplantation method: injection, aerosol, combined (aerosol+injection) and comparison group (standard skin grafting with split-thickness perforated transplants). There were 43 cases. Inclusion criteria: age 18-65 years, total area of skin burn 10-60% of body surface area, deep burn 10-45% of body surface area. Autologous skin grafting was performed on 10-15% of body surface area. Clinical, laboratory, cytological and histological methods were used to evaluate postoperative outcomes. Combined (injection+aerosol) transplantation method was followed by significantly earlier engraftment (by 5 days, 9.9 ±0.7 days in the main group and 14.5±0.88 days in the control group, Student's t test 3.518) and reduction of postoperative complications to 6% (in the control group 27%). Analysis of biotechnological methods for surgical treatment of patients with extensive deep burns showed the effectiveness of combined (aerosol+injection) tran

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence
HumansBurnsSkin TransplantationMaleFemaleAdultTransplantation, AutologousAdipose TissueMiddle AgedTreatment Outcome

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research